Skip to search formSkip to main contentSkip to account menu

L 651392

Known as: L 651.392, L-651,392, L-651392 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Inhibition of anaphylaxis-evoked intestinal fluid secretion by the dual application of an H1 antagonist and cyclooxygenase inhibitor.
1990
1990
Involvement of type I hypersensitivity in rapid rejection of Trichinella spiralis from adult rats.
The role of type I hypersensitivity in the rapid rejection of Trichinella spiralis from actively and passively immunized rats was… 
1990
1990
Modulation of the priming effects of platelet-activating factor on the release of interleukin-1 from lipopolysaccharide-stimulated rat spleen macrophages.
The pharmacologic modulation of the effect of platelet-activating factor (PAF) on the interleukin-1 (IL-1) activity present in… 
1989
1989
Sensitivity of immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxides.
1989
1989
Sulfidopeptide leukotrienes mediate acrolein-induced bronchial hyperresponsiveness.
The sulfidopeptide leukotrienes are bronchoconstrictive lipid mediators thought to have an important role in the pathophysiology… 
1989
1989
Leukocyte Stimulation of Intimal Lesion Formation Is Inhibited by Treatment with Diclofenac Sodium and Dexamethasone
This investigation tested the effect of anti-inflammatory agents acting at different levels of the arachidonic acid cascade on… 
1987
1987
L-651,392: a novel, potent and selective 5-lipoxygenase inhibitor.
1987
1987
5-Lipoxygenase inhibitors and allergic conjunctivitis reactions in the guinea-pig.
1987
1987
Effects of two novel inhibitors of 5-lipoxygenase, L-651,392 and L-651,896, in a guinea-pig model of epidermal hyperproliferation.
1987
1987
Effects of a 5-lipoxygenase inhibitor (L-651,392) and leukotriene D4 antagonist (L-649,923) in two animal models of immediate hypersensitivity reactions.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)